Overview of Dietary Supplements Labeling

Vitamins and minerals are micronutrients required by the body to carry out a range of normal functions. The regular diet of common man is obtained deficient in certain nutrients, so dietary supplements are commonly prescribed in this study combination of vitamins and minerals in the form of bilayer tablet is proposed as a dietary supplement. The current stud aimed to assess dietary supplement use and determine its associated factors among adult population in southern bangladesh In that we include, various nutraceuticals like prebiotic, probiotics, PUFA (poly unsaturated fatty acid), vitamins, spices, polyphenols and antioxidant vitamins etc. these neutraceuticals are used in eye health, mental health, sleep enhancement, cancer prevention, bone health, skin health and oral health. Dietary supplement used was more common in male as well as female. Common types on dietary supplement used in India are the multivitamin and multi-mineral products and health along with herbs for treatment of health or health promotion. Dietary supplements come in a variety of forms, including tablets, capsules, gummies, and powders as well as drinks and energy bars. Dietary food supplement is intended to provide nutrients that may otherwise not be consumed in sufficient manner. the supplement are generally understood as food they are included, vitamins, minerals, fibers, and fatty acid or amino acid, among other substance.

The prevalence of dietary supplement use among athletes continues to rise with 60–80% of athletes often reporting current or previous use of dietary supplements. While select dietary ingredients have been shown to improve acute performance and enhance training adaptations over time, it is important to still consider the risk vs. reward for athletes before opting to consume a dietary supplement. Previous work has indicated that certain dietary supplements may pose risks for inadvertent doping, may be susceptible to mislabelling, could be banned by certain governing bodies of sport, or pose health risks for certain populations. The purpose of the current narrative review is to summarize the prevalence of adulteration in dietary sport supplement products, outline the risks of inadvertent doping for athletes, and highlight best practices regarding safe supplementation strategies. Analytical studies have found anywhere from 14 to 50% of samples analyzed from dietary supplement products have tested positive for anabolic agents or other prohibited substances. It is important for the consumer to adhere to safe supplementation strategies, which include following serving size recommendations, cross-referencing ingredient profiles with the list of prohibited substances, choosing quality products that have been verified by a third-party certification program, and being cognizant of consuming multiple dietary supplement products with overlapping ingredient profiles. Once these practices have been considered, it is reasonable for an athlete to utilize dietary supplements as a strategy to optimize performance and health, with a low risk of failing a drug test (adverse analytical finding) and experiencing adverse events.

Use of dietary and herbal supplements in adult patients with epilepsy

BackgroundThere is a lack of information on the optimal timing of food supplementation to malnourished pregnant women and possible combined effects of food and multiple micronutrient supplementations (MMS) on their offspring's growth. We evaluated the effects of prenatal food and micronutrient interventions on postnatal child growth. The hypothesis was that prenatal MMS and early invitation to food supplementation would increase physical growth in the offspring during 0-54 months and a combination of these interventions would further improve these outcomes.MethodsIn the large, randomized MINIMat trial (Maternal and Infant Nutrition Interventions in Matlab), Bangladesh, 4436 pregnant women were enrolled between November 2001 and October 2003 and their children were followed until March 2009. Participants were randomized into six groups comprising 30 mg Fe and 400 μg folic acid (Fe30F), 60 mg Fe and 400 μg folic acid (Fe60F) or MMS combined with either an early (immediately after identification of pregnancy) or a later usual (at the time of their choosing, i.e., usual care in this community) program invitation to food supplementation. The anthropometry of 3267 children was followed from birth to 54 months, and 2735 children were available for analysis at 54 months.ResultsThere were no differences in characteristics of mothers and households among the different intervention groups. The average birth weight was 2694 g and birth length was 47.7 cm, with no difference among intervention groups. Early invitation to food supplementation (in comparison with usual invitation) reduced the proportion of stunting from early infancy up to 54 months for boys (p = 0.01), but not for girls (p = 0.31). MMS resulted in more stunting than standard Fe60F (p = 0.02). There was no interaction between the food and micronutrient supplementation on the growth outcome.ConclusionsEarly food supplementation in pregnancy reduced the occurrence of stunting during 0-54 months in boys, but not in girls, and prenatal MMS increased the proportion of stunting in boys. These effects on postnatal growth suggest programming effects in early fetal life.Trial registration numberISRCTN: ISRCTN16581394

Development of a new method for the determination of 4-hydroxyproline as a measurement of collagen content in meat products and dietary supplements by cyclodextrin-assisted electrokinetic chromatography

This investigation studied the effects of different levels and types of commercially available dietary fat supplements upon fatty acid composition in the adipose tissue of broiler chickens. Dietary fat supplements are used in the broiler chicken industry as an economical means of improving performance (Griffiths et al., 1977). Equal numbers of male and female Ross 1 broiler chickens were fed from birth on one of four alternative fat additives of widely differing fatty acid composition which were incorporated at 5% or 2.5% levels (diets A-D and E-H respectively) into the same approximately isocaloric diets. Details of dietary supplements, carcass processing, lipid extraction procedures and statistical procedures are given in an earlier report (Khan et al., 1986). After a modified Folch et al. (1957) extraction upon 0.4 g of adipose tissue, the lipid samples collected were used to prepare FAMES for gas chromatographic analysis by refluxing for 45 min at 70°C with methanolic sulphuric acid. After washing with NaCl and then NaHCO, solutions, the methyl esters were extracted with hexane, which was then removed at 50°C under a nitrogen stream. Analysis was performed with a Pye-Unicam PU 4500 gas chromatograph using a 2 m glass column filled with EGSS-X. FAMES were identified from retention times in comparison with standards (Sigma Co.) and quantified using a Pye-Unicam CDP1 integrator. The results show that dietary treatments (tested mutually by Kruskal-Wallis analysis of variance) significantly affected most adipose tissue fatty acids. These differences substantially reflect dietary supplement fatty acid composition which will be detailed elsewhere. In contrast, sex had no statistically significant effect upon fatty acid composition. The data presented here provide evidence that by feeding broiler chickens with suitable commercially available dietary fat supplements it is feasible to substantially influence the ratio of polyunsaturated to saturated fatty acids in chicken meat consumed by human beings.

Background and objectives: The use of dietary supplements is extremely common among cancer patients. It is estimated that 20–90% of cancer patients use some form of dietary supplement. Most often, they are “self-selected” supplements or selected from unverified Internet sources, without consulting a specialist. Components in such supplements can interact with the applied therapy and impact cancer patients’ treatment. The aim of this study was to examine the frequency and type of supplementation used by cancer patients. Methods: A cross-sectional observational study was conducted on 52 cancer patients (mean age: 58 years) by using a study-specific questionnaire, conducted between February and July 2022 at the University Clinical Hospital Mostar, Bosnia and Herzegovina. Results: More than half of the respondents (62%) use some dietary or herbal supplements daily. The most common dietary supplements were probiotics (22%), B complex vitamins (22%), and vitamin D (22%). Patients (46.8%) used supplements based on their own or their family–friend’s recommendation, and 90% of them started to use supplementation during therapy. The main reason for use, as stated by 71.8% of the respondents, was to support immunity. Approximately 56.2% of them said that they had noticed a positive effect on their health. It is concerning that 78.8% of patients did not research the possible side effects and risks of taking supplements during therapy. Conclusions: Doctors, nutritionists, and nurses should improve communication with patients by giving them reliable information and evidence-based recommendations about dietary supplements and complementary therapy in general. During consultations, professionals should offer assistance and discuss potential benefits and risks with the patient in order to achieve a mutually informed decision on dietary supplement use.

Clinical research has now shown that dietary supplements can be of benefit for geriatric patients, and many elders do take them. Understanding the science of dietary supplements is central to providing good medical counsel to geriatric patients. Like pharmaceuticals, there are attendant risks to the use of supplements, both intrinsic risks, and through drug-supplement interactions. In addition, the FDA does not regulate dietary supplements as stringently, so the medical provider must understand clearly the evidence of dietary supplements, as well as how to evaluate products on the market. This chapter reviews the science of dietary supplements, identifying mechanisms of action, indications, and adverse effects of beneficial dietary supplements. It also identifies a process of vetting supplements so as to optimize benefit while mitigating risks, with an emphasis on a shared decision-making model, so as to both inform patients and be clear in the medical record.

The use of dietary supplements (DSs) can lead to an excessive intake of certain nutrients, posing potential health risks. However, studies are scarce on whether DS users adhere to recommended doses provided by the manufacturer and what factors are associated with overconsumption of DS. By leveraging purchase history data to estimate DS use precisely, this study aimed to investigate the factors associated with DS consumption exceeding manufacturer-recommended doses and examine the prevalence of excess nutrient intake among DS users. An online survey was conducted from November to December 2024 among 2002 adults (aged 18-74 years) with a history of buying one of the 25 major DS products and who had used it in the previous month or regularly. Self-reported daily DS consumption was assessed using a questionnaire and compared to the manufacturer-recommended doses indicated in the package. Using multivariate logistic regression analysis, the associations between DS consumption exceeding the manufacturer-recommended doses and sociodemographic factors were examined. The prevalence of DS users exceeding tolerable upper intake levels (ULs), defined according to the Dietary Reference Intakes for Japanese, was calculated based on vitamin and mineral intake from DS only. Consequently, 371 (18.5%) of the 2002 participants consumed DS above the manufacturer-recommended dose. Consumption of DS above the recommended dose was associated with middle-aged, part-time or full-time employment, use of tablet-form DS, especially single water-soluble vitamin tablets, use of DS for 6 months or more, and intentional consumption above the recommended dose. For 1705 individuals consuming DS with UL nutrients, 17.4% (n=297) exceeded the manufacturer-recommended dose. Of these, 61.9% (184/297) surpassed UL by ≥1 nutrient. Middle-aged, part-time or full-time jobs, using tablet-form DS, and using DS for 6 months or more were associated with DS consumption exceeding the manufacturer-recommended dose, which may lead to excessive nutrient intake.

Growth patterns in early life are associated with later health. The effect of nutrition during in utero development on later body composition is unclear. We evaluated whether prenatal early invitation to food and/or multiple micronutrient supplementation (MMS) in pregnancy has an effect on offspring body composition at 54 months of age. In Maternal and Infant Nutrition Interventions in Matlab trial (ISRCTN16581394) in Bangladesh, 4436 pregnant women were randomised into six equally sized groups: double-masked supplementation with capsules of either 30 mg Fe and 400 μg folic acid, or 60 mg Fe and 400 μg folic acid, or MMS (15 micronutrients), was combined with a randomised early invitation (around 9 weeks) or a usual invitation (around 20 weeks) to start food supplementation (608 kcal 6 days per week). At 54 months, the body composition of the offspring was assessed by leg-to-leg bioelectrical impedance analysis. Of the 3267 live singletons with birth anthropometry, 2290 children were measured at 54 months, representing 70% of the live births. There was no interaction between the food and micronutrient supplementation on body composition outcomes. There were no significant differences in a range of anthropometric and body composition measurements, including weight, height, mid-upper arm circumference, head circumference, skinfold thickness, and fat mass and fat-free mass between the different prenatal food and micronutrient groups using an intention-to-treat analysis. This analysis shows that early invitation to food supplementation and MMS provided to rural Bangladeshi women during pregnancy did not affect offspring body composition at 54 months of age.

Some patients use dietary supplements and medicines concomitantly, with an inappropriate perception of their safety and efficacy. To clarify the perception between dietary supplement and medicine users and non-users, we conducted an internet survey. In this survey, 38.9% of participants used dietary supplements, 32.6% used prescription medicines, and 14.7% used dietary supplements and prescription medicines concomitantly. Then, we conducted a further survey on four groups, dietary supplement and prescription medicine users, dietary supplement only users, prescription medicine only users, and non-users (500 each). Dietary supplement users had favorable outcomes in terms of both the safety and efficacy of dietary supplements compared to dietary supplement non-users. This perception of dietary supplements was independent from medicine use. The awareness of the Health Food Network consumer navigation site, which provides information about dietary supplements for consumers, was the highest among dietary supplement and prescription medicine users, but it was still low (2.2%). In conclusion, consumers who use dietary supplement and prescription medicine concomitantly have favorable outcomes for their safety and efficacy and a low awareness of their interaction. There is a need to provide information, especially regarding the risk of interaction, that takes into account the consumer’s situation.

Back to table of contents Previous article Next article Professional NewsFull AccessFDA Said to Miss Adverse Events Caused by Dietary SupplementsJun YanJun YanSearch for more papers by this authorPublished Online:19 Apr 2013https://doi.org/10.1176/appi.pn.2013.4b21AbstractContrary to common perception, dietary supplements are not always safe, but the FDA is hampered by a lack of money to collect useful data and monitor safety problems.When it comes to protecting the public from the side effects and toxicities of dietary supplements, the Food and Drug Administration’s (FDA) current adverse-event reporting system is missing a substantial chunk of the complaints that consumers have registered, according to a Government Accountability Office (GAO) report released March 18.Dietary supplements, which include vitamins, minerals, and herbal products, constitute a $30-billion annual business in the United States, and the demand for these products is increasing, according to 2011 estimates published by Nutrition Business Journal. The FDA estimated that about 55,000 dietary supplement products were on the market in 2009. Dietary supplements are primarily regulated by the FDA’s Center for Food Safety and Applied Nutrition (CFSAN), and the agency’s total regulatory activities in this area, ranging from inspections to safety surveillance, had a budget of $18.9 million in 2012, the GAO noted. Unlike prescription drugs, however, dietary supplements can be marketed without the manufacturer having to prove their efficacy and safety. The burden of proof is on the FDA to demonstrate that a product is unsafe or harmful before actions can be taken. To date, one herbal ingredient, ephedrine alkaloids, which was used in weight-loss supplements, has been banned because of its link to several deaths. For less-grave risks, the FDA can issue warning letters, seek court injunctions, block importation, or issue recalls for supplement products that fail inspections, contain adulterated ingredients, or pose other safety risks. In 2011, the agency issued about 90 warning letters related to dietary supplements and 30 voluntary-recall requests. If consumers suffer adverse effects from a dietary supplement, they can report the problem directly to the FDA’s MedWatch program, an online reporting portal (see URL at end of article). These reports are then transferred to CFSAN for evaluation. Consumers can also file a complaint with a local FDA field office or with the supplement’s manufacturer or distributor, whose telephone number is required on the package. Starting in 2008, manufacturers or distributors were required to submit adverse-event reports to the FDA if the event is deemed serious. If the event is not considered serious, the manufacturer is not obligated but can voluntarily report it.(The FDA defines a serious event as one that results “in a death, life-threatening experience, inpatient hospitalization, or birth defect or…require[s] a medical or surgical intervention to prevent the above-cited serious outcomes.”)From 2008 to 2011, the FDA received 6,307 adverse-event reports for dietary supplements, 71 percent of which came from the industry, reported as serious adverse events, according to the GAO audit. The GAO also found that from 2008 to 2010, 57 U.S. poison centers received 4,863 calls about adverse events related to dietary supplements, which was about 1,000 more reports than the FDA received in the same three-year period. These reports were generally not shared with the FDA, the GAO found.Although the GAO recommends that the FDA obtain comprehensive adverse-event data from poison centers, CFSAN officials told the GAO that purchasing poison-center data would be cost prohibitive, as the CFSAN annual budget for adverse-event surveillance is about $400,000, far less than the price poison centers want to charge for the data. Underreporting of adverse events is a constant concern. The GAO report cited reasons for underreporting supplement-related adverse events, in particular that “consumers, health care professionals, and others may not recognize the chronic or cumulative toxic effects of a dietary supplement, or…assume dietary supplements to be safe and not attribute negative effects to them.” ■FDA-issued product recalls are posted at http://www.fda.gov/Safety/MedWatch/default.htm ISSUES NewArchived

Dietary supplement use is common among children and adolescents. During 2013-2014, approximately one third of children and adolescents (persons aged ≤19 years) in the United States were reported to use a dietary supplement in the past 30 days, and use varied by demographic characteristics (1,2). Dietary supplements can contribute substantially to overall nutrient intake, having the potential to both mitigate nutrient shortfalls as well as to lead to nutrient intake above recommended upper limits (3). However, because nutritional needs should generally be met through food consumption according to the 2015-2020 Dietary Guidelines for Americans, only a few dietary supplements are specifically recommended for use among children and adolescents and only under particular conditions (4). The most recently released data from the National Health and Nutrition Examination Survey (NHANES) during 2017-2018 were used to estimate the prevalence of use among U.S. children and adolescents of any dietary supplement, two or more dietary supplements, and specific dietary supplement product types. Trends were calculated for dietary supplement use from 2009-2010 to 2017-2018. During 2017-2018, 34.0% of children and adolescents used any dietary supplement in the past 30 days, with no significant change since 2009-2010. Use of two or more dietary supplements increased from 4.3% during 2009-2010 to 7.1% during 2017-2018. Multivitamin-mineral products were used by 23.8% of children and adolescents, making these the products most commonly used. Because dietary supplement use is common, surveillance of dietary supplement use, combined with nutrient intake from diet, will remain an important component of monitoring nutritional intake in children and adolescents to inform clinical practice and dietary recommendations.

In 1994, after intensive lobbying by the supplement industry, US federal legislation passed the Dietary Supplement Health and Education Act, and essentially removed so-called ‘dietary supplements’ from the US Food and Drug Administration control. Some companies are marketing herbal medications in the USA as dietary supplements. Even some dietary supplement manufacturers produce a ‘mimic drug’ rather than a ‘dietary supplement’. The US Food and Drug Administration is able to do nothing except wait for the next incident to occur before other dietary supplement products have also caused serious effects. In the present article, the author discusses international regulations and laws of dietary supplements, and hopes to see more new laws and regulations to assure people of continued access to high-quality natural healthcare products and dietary supplements.

Consumption and reasons for use of dietary supplements in an Australian university population